Retina

The rate of change in flicker sensitivities is helpful in predicting geographic atrophy (GA)

It is possible for AMD patients to maintain BCVA for fives years after macular translocation surgery..

The combination of diabetes and hypertension-potentiated retinal oxidative and inflammatory stress accelerates retinal cell death and acellular capillary formation.

New anatomic characteristics of peripapillary intrachoroidal cavitation have been identified using optical coherence tomography (OCT).

The warning signs of childhood eye cancer retinoblastoma will be included in the new edition of the Personal Child Health Record.

Focal lamina cribrosa (LC) occurs in conjunction with neuroretinal rim and visual field loss.

Ozurdex has been accepted by the Scottish Medicines Consortium for use within the NHS in Scotland.

The perfluoro-n-octane (PFO) tamponade is a safe and effective short-term vitreous substitute in primary rhegmatogenous retinal detachment repair

Peripheral yellow corneal rings are more common in age-related macular degeneration (AMD).

Advanced Retinal Therapy will be held in Vienna, Austria on 3 December 2011. At this event updates, trends and controversies in retinal tehrapy will be discussed in symposia, key-note lectures and a panel discussion session.

The National Institute for Health and Clinical Excellence (NICE) has recommended Ozurdex for the treatment of macular oedema caused by central retinal vein occlusion (CRVO).

Anticoagulation (warafin) therapy was linked to a higher risk of post vitreoretinal surgery (VRS) bleeding in comparison with antipletelet (aspirin, clopidogrel) therapy vitreoretinal.

Anti-vascular endothelial growth factor agent well-tolerated, met primary efficacy endpoint.

The answer may be found in the masking effects of catract upon pre-existing disease

OTEurope speaks with Dr Wolfgang Schalch about 'Critical parameters for lutein delivery systems' and the Actilease system.

This new technology will enable surgeons to perform treatments more accurately and comfortably in a short period of time.

Diagnostic and prognostic capabilities at the early stages of retinal diseases could be improved as a result of adaptive optics.

Dr Sunir Gard reveals some of the more common problems that can be encountered with MIVS and how to cope with them.

First in-human study of human umbilical tissue-derivedcaeels as a therapy for retinal degenerative diseases shows promise.

Dr Sebasiten Wolf describes how SD-OCT has improved the visualization of intraretinal morphologic feaures both quantatively and qualatively.

A case study involving a patient with a macular pucker with a partial posterior vitreous detachment

A novel nanosecond laser therapy has stopped the progression of age-related macular degeneration (AMD) and resulted in resolution of drusen and improved visual function in patients with early-stage high-risk AMD.

A specific diode laser is the latest technology to perform several different laser procedures in the ophthalmic practice. Its multi-use capabilities for glaucoma and retinal disease make it a strong choice for the office setting.

Combined genomic and proteomic biomarkers are seemingly the most effective method for predicting progression.

A report on the status of the 5-year-old ongoing MacTel Project, which is slowly answering questions surrounding the disease.

The efficacy and safety of two doses of a fluocinolone acetonide intravitreal insert for the treatment of DME were investigated in two sham-controlled phase III studies

Results of a recent clinical study provide promising evidence of the value of ultra-widefield fundus autofluorescence (FAF) imaging in the evaluation of age-related macular degernation (AMD)

A rare case of bilateral pigmented atrophic changes in the macular region associated with topiramate treatment for chorioathetosis in a young female is reported.

Results from preclinical testing including a formal Good Laboratory Practice toxicity study, support the safety of a gene transfer agent, AAV2-sFLT01, when administered intravitreally. A phase I safety and tolerability study of this agent is currently underway.

Study shows little difference between these forms of endotamponade in patients with PVR